zum Inhalt springen

Healthcare industry in the Covid-19 pandemic: How to use the full potential of Europe’s healthcare industry

Datum

10:30 - 15:30 Uhr
Ort
Online
Kosten
kostenfrei
Art
Webinar
Veranstalter
Ministerium für Wirtschaft, Arbeit und Wohnungsbau Baden-Württemberg
Sprache
Englisch

Die nachfolgenden Informationen sind ausschließlich in englischer Sprache verfügbar:

Program:

10.30 - 12.30 | Political Strategies/ Positions/ Best-practice-Examples

  • Pharmaceutical Industry: Strategies for a competitive Europe
    Competitiveness / European value chain
  • Medtech: Improving the potential for innovations despite the crisis
    Role of diagnostics / regulatory framework
  • Smart Health: Seizing oppurtunities of the digital age
    European Health Data Space / Smart Health Strategic Value Chain

Opening of the conference "The importance of the healthcare industry"

  • Dr. Nicole Hoffmeister-Kraut MdL, Minister of Economic Affairs, Labour and Housing Baden-Württemberg

Baden-Württemberg case example

  • Dr. Florian von der Mülbe, Chief Production Officer and co-founder, CureVac AG
  • Dr. Günter Roth, CEO, BioCopy GmbH

Panel: "Healthcare industry in the Covid-19 pandemic: How to use Europe's full potential"

  • Dr. Nicole Hoffmeister-Kraut MdL, Minister of Economic Affairs, Labour and Housing Baden-Württemberg
  • Andrzej Rys, DG SANTE, Director, Health systems, medical products and innovation
  • Andreas Glück, Member of the European Parliament, FDP
  • Dr. Andreas Schwab, Member of the European Parliament, CDU
  • Professor Dr. Hagen Pfundner, Executive Board of Roche Pharma AG
  • Professor Dr. Katja Schenke-Layland, Professor at the Womens Hospital Eberhard-Karls-University Tübingen and Director of the Natural and Medical Science Institute Reutlingen
  • Professor Dr. Mark Dominik Alscher, Medical Managing Director, Robert Bosch Hospital Stuttgart
  • Dr. Martin Leonhard, Executive Director Technology Management KARL STORZ SE & Co. KG and MedTech Chairman at Spectaris -German industry association for Optics, Photonics, Analytical and Medical Device Technologies
  • Professor Dr. Ralf Kindervater, CEO BIOPRO Baden-Württemberg GmbH (moderator)

12.30 - 14.00 | Break

14.00 - 15.30 | Exchange of experiences/ Study Cases/ Concrete Solutions

Parallel roundtables with discussions of Experts

1. Roundtable on Medtech:
How can the European regulatory framework promote the future of medtech?

  • Andrzej Rys, DG SANTE, Director, Health Systems, medical products and innovation
  • Julia Steckeler, Managing Director, MedicalMountains GmbH
  • Oliver Bisazza, Director Regulations & Industrial Policy, MedTech Europe
  • Dr. Martin Leonhard, Executive Director Technology Management KARL STORZ SE & Co. KG and MedTech Chairman at Spectaris -German industry association for Optics, Photonics, Analytical and Medical Device Technologies
  • Dirk Schick, Head of Market Development Germany, Roche Diagnostics and Board Member of the German Industry Association for Diagnostics (VDGH)
  • Professor Dr. Ralf Kindervater, CEO BIOPRO Baden-Württemberg GmbH (moderator)

2. Roundtable on Pharmaceuticals (phytopharmaceuticals):
How to ensure the competitiveness of European herbal medicines?

  • Introduction: “Health Claims Regulation – Background, progress and status quo” by Dr. Michael Weidner, Kozianka & Weidner law firm
  • Dr. Martin Braun, Head of Production Germany, Dr. Willmar Schwabe GmbH & Co. KG
  • Mathias Arnold, Vice President, Pharmaceutical Group of the European Union
  • Dr. Emiel van Galen, Chair of the committee on Herbal Medicinal Products (EMA)
  • Jutta Paulus, Member of the European Parliament
  • Dr. Alexander Natz, CEO EUCOPE (moderator)

3. Roundtable on Smart Health:
How to make the most of Europe's data?

  • Tobias Wiesenthal, DG CNECT, Head of Sector Research and Innovation, eHealth, Well-Being and Ageing
  • Axel Voss, Member of the European Parliament
  • Cristina De Capitani, Cluster Manager, Lombardy Cluster "Technologies for Living Environments"
  • Professor Dr. Mark Dominik Alscher, Medical Managing Director, Robert Bosch Hospital Stuttgart
  • Professor Dr. Katja Schenke-Layland, Professor at the Womens Hospital Eberhard-Karls-University Tübingen and Director of the Natural and Medical Science Institute Reutlingen
  • Professor Dr. Oliver G. Opitz, Head of the Coordination Centre for Telemedicine Baden-Württemberg (moderator)

Seiten-Adresse: https://www.bio-pro.de/veranstaltungen/healthcare-industry-covid-19-pandemic